Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Polyneuropathy in non-Hodgkin lymphoma]

M Bilińska1, L Usnarska-Zubkiewicz, M Ejma

  • 1Katedry i Kliniki Neurologii AM we Wrocławiu.

Neurologia I Neurochirurgia Polska
|May 1, 1995
PubMed
Summary

Treatment with oncovin can cause axonal sensorimotor polyneuropathy in 15% of non-Hodgkin lymphoma patients. This nerve damage is linked to treatment, not the specific cancer type, highlighting therapy as a key risk factor.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Status of retained deciduous second molars in subjects with agenesis of second premolars in relation to age.

European journal of paediatric dentistry·2023
Same author

Computed tomography with positron emission tomography is more useful in local than systemic infectious process related to cardiac implanted electrotherapy device: a prospective controlled multicenter diagnostic intervention PET-Guidance Trial.

The international journal of cardiovascular imaging·2022
Same author

Diffusion tensor imaging findings in the multiple sclerosis patients and their relationships to various aspects of disability.

Journal of the neurological sciences·2018
Same author

Effect of Selective Antibiotic Pressure on the MLS-B Phenotype in Methicillin-Resistant Staphylococcus aureus Strains Originating From Patients From Transplantation Wards: 24 Years of Observations.

Transplantation proceedings·2018
Same author

Wasp Venom Immunotherapy in a Patient With Immune-Mediated Inflammatory Central Nervous System Disease: Is it Safe?

Journal of investigational allergology & clinical immunology·2017
Same author

Characteristics of the expression of KAI1/CD82 and PDGFRβ and their impact on glioma progression.

Folia neuropathologica·2016

Area of Science:

  • Neurology
  • Oncology

Context:

  • Non-Hodgkin lymphoma (NHL) patients often experience neurological complications.
  • Axonal sensorimotor polyneuropathy is a potential adverse effect of cancer therapy.

Purpose:

  • To investigate the incidence and characteristics of axonal sensorimotor polyneuropathy in non-Hodgkin lymphoma patients.
  • To determine the correlation between polyneuropathy and specific cancer types or treatments.

Summary:

  • A study of non-Hodgkin lymphoma patients revealed axonal sensorimotor polyneuropathy in 15% of cases.
  • The polyneuropathy was observed in patients undergoing treatment, particularly those receiving oncovin.
  • No correlation was found between polyneuropathy and the specific type of malignancy, suggesting treatment is the primary causative factor.

Related Experiment Videos

Impact:

  • This research underscores the importance of monitoring for and managing treatment-induced polyneuropathy in non-Hodgkin lymphoma patients.
  • Findings emphasize the need for further investigation into oncovin's neurotoxic effects and potential mitigation strategies.